Home / Market News / $HSIC

$HSIC news and market catalysts

The 6 most recent market catalysts affecting $HSIC, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

6 catalysts 0 high impact 5 bullish 0 bearish Healthcare Distribution
Sep 25, 2026 Corporate Catalyst Neutral Impact 75
Transcript: Henry Schein Q2 2026 Earnings Conference Call
Henry Schein's Q2 2026 earnings call transcript reveals a strong financial quarter with significant sales and non-GAAP EPS growth, prompting the company to raise its full-year guid…
Aug 19, 2026 Corporate Catalyst Bullish Impact 55
BTIG Maintains Buy on Henry Schein, Raises Price Target to $110
BTIG analyst David Larsen has maintained a 'Buy' rating on Henry Schein (HSIC) and raised the price target from $100 to $110. This upward revision in the price target indicates inc…
Aug 6, 2026 Corporate Catalyst Bullish Impact 60
Barclays Maintains Overweight on Henry Schein, Raises Price Target to $100
This filing discloses that Barclays, through its analyst Glen Santangelo, has raised its price target for Henry Schein (HSIC) from $86 to $100, while maintaining an 'Overweight' ra…
Aug 5, 2026 Corporate Catalyst Bullish Impact 55
Citigroup Maintains Buy on Henry Schein, Raises Price Target to $112
Citigroup analyst Daniel Grosslight maintained a 'Buy' rating on Henry Schein (HSIC) and raised the price target from $100 to $112. This indicates a strengthened positive outlook f…
Aug 4, 2026 Corporate Catalyst Bullish Impact 75
Henry Schein Q2 Adj. EPS $1.27 Beats $1.24 Estimate, Sales $3.458B Beat $3.375B Estimate
Henry Schein (HSIC) announced Q2 adjusted EPS of $1.27, beating the $1.24 estimate, and sales of $3.458 billion, exceeding the $3.375 billion estimate. This strong financial perfor…
Jul 29, 2026 Corporate Catalyst Bullish Impact 55
Piper Sandler Maintains Overweight on Henry Schein, Raises Price Target to $95
Piper Sandler analyst Jason Bednar has maintained an 'Overweight' rating on Henry Schein (HSIC) and raised the price target from $91 to $95. This action signals continued confidenc…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.